Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Aspen Pharmacare Holdings's current 10-Year Share Buyback Ratio was 0.30%.
APNHY's 10-Year Share Buyback Ratio is ranked better than 88.65% of 617
companies
in the Drug Manufacturers industry
Industry Median: -2.1
vs APNHY: 0.30
Aspen Pharmacare Holdings (OTCPK:APNHY) 10-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Aspen Pharmacare Holdings 10-Year Share Buyback Ratio Related Terms
APNHY vs ZTS, UTHR, VTRS: 10-Year Share Buyback Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspen Pharmacare Holdings 10-Year Share Buyback Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's 10-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Aspen Pharmacare Holdings's 10-Year Share Buyback Ratio falls into.
Aspen Pharmacare Holdings 10-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 10-Year Share Buyback Ratio of 0.30 mean?
Aspen Pharmacare Holdings (APNHY) has a 10-Year Share Buyback Ratio of 0.30 as of Dec. 2025. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Aspen Pharmacare Holdings and its competitors. According to the industry distribution chart, Aspen Pharmacare Holdings ranks #70 out of 617 companies in the Drug Manufacturers industry, placing it in the top 11.3%.
Is Aspen Pharmacare Holdings' 10-Year Share Buyback Ratio too high?
Aspen Pharmacare Holdings' current 10-Year Share Buyback Ratio is 0.30. Based on the distribution chart, Aspen Pharmacare Holdings ranks #70 out of 617 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Aspen Pharmacare Holdings has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' 10-Year Share Buyback Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aspen Pharmacare Holdings ranks #70 out of 617 companies for 10-Year Share Buyback Ratio. This places Aspen Pharmacare Holdings in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Share Buyback Ratio for a Drug Manufacturers company?
A good 10-Year Share Buyback Ratio depends on the Drug Manufacturers industry context. However, 10-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Share Buyback Ratio mean?
A high 10-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Aspen Pharmacare Holdings and its competitors. Aspen Pharmacare Holdings's current 10-Year Share Buyback Ratio is 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (APNHY) is currently considered Fairly Valued. The stock's GF Value™ is $10.02, compared to a current price of $9.72 — trading 3% below its estimated fair value. The current 10-Year Share Buyback Ratio is 0.30. Aspen Pharmacare Holdings' overall GF Score™ is 70/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Share Buyback Ratio calculated?
10-Year Share Buyback Ratio is calculated from a company's financial statements. For Aspen Pharmacare Holdings (APNHY), the current 10-Year Share Buyback Ratio is 0.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aspen Pharmacare Holdings (APNHY) Overvalued in 2026?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued.
The current stock price of $9.72 is trading 3% below its estimated GF Value™ of $10.02.
GuruFocus considers Aspen Pharmacare Holdings to be Fairly Valued.
Key valuation signals for APNHY:
10-Year Share Buyback Ratio: 0.30
GF Value™: $10.02 vs. price of $9.72 (3% below fair value)
No single metric tells the full story. See the APNHY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
70GF Score
Get the complete analysis for APNHY
10-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
APNHY has been successfully added to your 
